Scandion Oncology AS (OSTO:SCOL) FCF Yield % : -1,719.49 (As of Apr. 25, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology AS FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Scandion Oncology AS's Trailing 12-Month Free Cash Flow is kr-41.99 Mil, and Market Cap is kr2.44 Mil. Therefore, Scandion Oncology AS's FCF Yield % for today is -1,719.49%.

The historical rank and industry rank for Scandion Oncology AS's FCF Yield % or its related term are showing as below:

OSTO:SCOL' s FCF Yield % Range Over the Past 10 Years
Min: -1719.49 Med: 0 Max: 0
Current: -1719.49

OSTO:SCOL's FCF Yield % is ranked worse than
98.8% of 1498 companies
in the Biotechnology industry
Industry Median: -14.885 vs OSTO:SCOL: -1719.49

Scandion Oncology AS's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Scandion Oncology AS FCF Yield % Historical Data

The historical data trend for Scandion Oncology AS's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandion Oncology AS FCF Yield % Chart

Scandion Oncology AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-3.70

-17.40

-90.57

-46.76

-242.69

Scandion Oncology AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-36.64	-56.82	-35.02	-220.39	-64.13

Competitive Comparison of Scandion Oncology AS's FCF Yield %

For the Biotechnology subindustry, Scandion Oncology AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scandion Oncology AS's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scandion Oncology AS's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Scandion Oncology AS's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Scandion Oncology AS FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Scandion Oncology AS's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-42.446	/	17.489769
	=	-242.69%

Scandion Oncology AS's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.804	*	4	/	17.489769
	=	-64.13%

Scandion Oncology AS FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Scandion Oncology AS FCF Yield % Related Terms

Thank you for viewing the detailed overview of Scandion Oncology AS's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Scandion Oncology AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology AS (OSTO:SCOL) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

8VY:Germany

Address

Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100

Website

https://www.scandiononcology.com

Scandion Oncology AS is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options. The company's pipeline includes products like COROST for Colorectal Cancer, PANTAX for Pancreatic Cancer, 101 for other cancer indiction, 201 for Solid Tumors.

Scandion Oncology AS Headlines

No Headlines